FZMD Stock Overview
Manufactures and distributes medical devices in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Fuse Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.061 |
| 52 Week High | US$0.12 |
| 52 Week Low | US$0.016 |
| Beta | 0 |
| 1 Month Change | -49.04% |
| 3 Month Change | 1.67% |
| 1 Year Change | -32.37% |
| 3 Year Change | -81.51% |
| 5 Year Change | -89.48% |
| Change since IPO | -95.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| FZMD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 1.2% |
| 1Y | -32.4% | -5.1% | 21.0% |
Return vs Industry: FZMD underperformed the US Healthcare industry which returned -5.1% over the past year.
Return vs Market: FZMD underperformed the US Market which returned 21% over the past year.
Price Volatility
| FZMD volatility | |
|---|---|
| FZMD Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 18.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FZMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine FZMD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Chris Reeg | www.fusemedical.com |
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues.
Fuse Medical, Inc. Fundamentals Summary
| FZMD fundamental statistics | |
|---|---|
| Market cap | US$4.41m |
| Earnings (TTM) | US$3.98m |
| Revenue (TTM) | US$18.40m |
0.0x
P/E Ratio0.0x
P/S RatioIs FZMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FZMD income statement (TTM) | |
|---|---|
| Revenue | US$18.40m |
| Cost of Revenue | US$6.03m |
| Gross Profit | US$12.38m |
| Other Expenses | US$8.40m |
| Earnings | US$3.98m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did FZMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/11 01:25 |
| End of Day Share Price | 2025/02/04 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fuse Medical, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.